These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence. Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087 [TBL] [Abstract][Full Text] [Related]
6. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin. Dai J; Allard WJ; Davis G; Yeung KK Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094 [TBL] [Abstract][Full Text] [Related]
8. Affinity of antibodies to MUC1 antigens. Karanikas V; Patton K; Jamieson G; Pietersz G; McKenzie I Tumour Biol; 1998; 19 Suppl 1():71-8. PubMed ID: 9422091 [TBL] [Abstract][Full Text] [Related]
9. Proceedings of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) TD-4 International Workshop on Monoclonal Antibodies against MUC1. San Diego, California, November 17-23, 1996. Tumour Biol; 1998; 19 Suppl 1():1-152. PubMed ID: 9441368 [No Abstract] [Full Text] [Related]
10. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies. Lloyd KO; Kudryashov V Tumour Biol; 1998; 19 Suppl 1():118-21. PubMed ID: 9422096 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1. Reis CA; Hassan H; Bennett EP; Clausen H Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613 [TBL] [Abstract][Full Text] [Related]
17. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660 [TBL] [Abstract][Full Text] [Related]
18. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429 [TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of PR81 anti-MUC1 monoclonal antibody following PEPSCAN and phage display techniques. Mohammadi M; Rasaee MJ; Rajabibazl M; Paknejad M; Zare M; Mohammadzadeh S Hybridoma (Larchmt); 2007 Aug; 26(4):223-30. PubMed ID: 17725384 [TBL] [Abstract][Full Text] [Related]
20. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells. Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]